Search hospitals

>

Maine

>

Scarborough

Maine Medical Center- Scarborough Campus

Claim this profile

Scarborough, Maine 04074

Global Leader in Ovarian Cancer

Global Leader in Breast Cancer

Conducts research for Cancer

Conducts research for Fallopian Tube Cancer

Conducts research for Lung Cancer

99 reported clinical trials

16 medical researchers

Photo of Maine Medical Center- Scarborough Campus in ScarboroughPhoto of Maine Medical Center- Scarborough Campus in ScarboroughPhoto of Maine Medical Center- Scarborough Campus in Scarborough

Summary

Maine Medical Center- Scarborough Campus is a medical facility located in Scarborough, Maine. This center is recognized for care of Ovarian Cancer, Breast Cancer, Cancer, Fallopian Tube Cancer, Lung Cancer and other specialties. Maine Medical Center- Scarborough Campus is involved with conducting 99 clinical trials across 161 conditions. There are 16 research doctors associated with this hospital, such as Eric C. Larsen, Matthew D. Cheney, Leslie Bradford, MD, and Peter Rubin.

Area of expertise

1

Ovarian Cancer

Global Leader

Maine Medical Center- Scarborough Campus has run 25 trials for Ovarian Cancer. Some of their research focus areas include:

BRCA1 positive
Stage IV
BRCA2 positive
2

Breast Cancer

Global Leader

Maine Medical Center- Scarborough Campus has run 17 trials for Breast Cancer. Some of their research focus areas include:

HER2 negative
HER2 positive
ER positive

Top PIs

Clinical Trials running at Maine Medical Center- Scarborough Campus

Ovarian Cancer

Prostate Cancer

Lung Cancer

Breast Cancer

Cancer

Breast cancer

Esophageal cancer

Fallopian Tube Cancer

Uterine Cancer

Pancreatic Cancer

Image of trial facility.

Mirvetuximab + Bevacizumab

for Ovarian Cancer

GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine + Bevacizumab as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.

Recruiting

2 awards

Phase 3

Image of trial facility.

LY4170156

for Ovarian Cancer

This is a clinical study that has two parts. It is testing a potential new medicine called Sofetabart Mipitecan (LY4170156) for people with certain types of ovarian, peritoneal, and fallopian tube cancers. Part A looks at participants whose cancer no longer responds to platinum-based treatments (a type of chemotherapy). Part B looks at participants whose cancer still responds to platinum-based treatments. The researchers want to find out if Sofetabart Mipitecan works better than the usual treatments that doctors use now and to better understand how safe it is. Each participant's time in the study will depend on how they respond to the treatment.

Recruiting

2 awards

Phase 3

4 criteria

Image of trial facility.

Blood Sample Collection

for Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.

Recruiting

1 award

N/A

9 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Maine Medical Center- Scarborough Campus?